Very interesting territory for this companies earnings. They haven't sold anything new but have been getting gov't funding and donors. GILD gave away their supply of treatment.
Personally I think earnings will be bad but will still rise into it.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.